DENVER--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the U.S. commercial availability of Covidien Imaging Solutions’ contrast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback